| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/03/2008 | EP0950098B1 Stable expression of triple helical proteins |
| 09/03/2008 | EP0934339B1 Detoxification by intramuscular administration of F(ab') 2 fragments |
| 09/03/2008 | EP0923940B1 Peptide-based immunotherapeutic agent for allergic diseases |
| 09/03/2008 | EP0906577B1 Screening compounds for the ability to alter the production of amyloid-beta peptide |
| 09/03/2008 | EP0906340B2 Purification of factor viii complex by immunoaffinity chromatography |
| 09/03/2008 | EP0804576B1 A novel haemopoietin receptor |
| 09/03/2008 | EP0789575B1 Peripheral nervous system specific sodium channels, dna encoding therefor, drug screening, and methods of making and using thereof |
| 09/03/2008 | EP0781331B1 Improvements in or relating to binding proteins for recognition of dna |
| 09/03/2008 | CN101258240A Protein preparation containing S1-5 |
| 09/03/2008 | CN101257918A Use of a cytokine from the interleukin-6 family in the preparation of a composition for combined administration with interferon-alpha |
| 09/03/2008 | CN101257917A Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection |
| 09/03/2008 | CN101257916A 黑皮质素受体配体 Melanocortin receptor ligands |
| 09/03/2008 | CN101257915A Method of inhibiting angiogenesis by using ephrin B2 |
| 09/03/2008 | CN101257914A Composition for amelioration of body lipid |
| 09/03/2008 | CN101257885A Dental composition comprising enzyme |
| 09/03/2008 | CN101255441A AFP recombinant gland related viral vectors as well as construction method and uses thereof |
| 09/03/2008 | CN101255425A OX2 receptor homolog |
| 09/03/2008 | CN101255411A Method for constructing hepatitis C virus specific ribozyme M1GS-hcv/C67 and uses thereof |
| 09/03/2008 | CN101255410A Method for constructing hepatitis C virus specific ribozyme M1GS-hcv/C76 and uses thereof |
| 09/03/2008 | CN101255197A Fusion protein for serum albumin and interleukin 1 receptor antagonist and uses thereof |
| 09/03/2008 | CN101255192A Soluble CTLA4 mutant molecules and uses thereof |
| 09/03/2008 | CN101255191A Micro-wave promoted solid-phase synthesis of glucagons-like peptide-1(GLP-1) analogue and uses thereof |
| 09/03/2008 | CN101255190A Use of human midkine protein blocking peptide in preparation of antitumor medicament |
| 09/03/2008 | CN101255188A Methods for conversion of interferon isoforms and products thereof |
| 09/03/2008 | CN101255123A Amino acid derived prodrugs of propofol, compositions and uses thereof |
| 09/03/2008 | CN101254304A Medicaments for treating micro-organism infection and use thereof |
| 09/03/2008 | CN101254300A Intestinotrophic glucagon-like peptide-2 analogs |
| 09/03/2008 | CN101254299A Therapy of diabetic under bark dysfunction |
| 09/03/2008 | CN101254298A Hoarfrost agent for antioxidation and improving human body immunity and method of preparing the same |
| 09/03/2008 | CN101254228A Preparation of Yin-nourishing and Yang-strengthening arctium lappa element |
| 09/03/2008 | CN101254210A Gelatine plasma substitutes and method of preparing the same |
| 09/03/2008 | CN101254203A Pharmaceutical combination for curing acute radiation dermatitis |
| 09/03/2008 | CN100415895C Non-splicing variant of gp 350/220 |
| 09/03/2008 | CN100415772C Anti-ErbB2 antibodies |
| 09/03/2008 | CN100415770C 2-{[N-(2-amino-3-(heteroaryl or aryl) propionyl)-aminoacyl]-amino}- alkylboronic acid derivatives |
| 09/03/2008 | CN100415299C Correlation factor of blastocyst nidation and application |
| 09/03/2008 | CN100415296C Compositions containing inclusion complexes |
| 09/03/2008 | CN100415293C Biological collagen oral liquor and preparing method thereof |
| 09/03/2008 | CN100415292C New class of bioactive glycoprotein |
| 09/03/2008 | CN100415225C Novel use of peptide class of compound for treating non-neuropathic inflammatory pain |
| 09/03/2008 | CN100415219C Substituted bicyclo[3.3.1]nonan-2,4,9-triones as pharmaceutical active ingredients |
| 09/03/2008 | CN100415210C Peptide/lipid complex formation by co-lyophilization |
| 09/03/2008 | CN100415093C Autologous or homologous coagulant produced from anticoagulated whole blood |
| 09/02/2008 | US7420100 Animal model lacking histone deacetylase (HDAC) for use as diagnostic tool in detection, diagnosis and prevention of cardiac hypertrophy |
| 09/02/2008 | US7420085 Form II; used for facilitating the delivery of active agents, such as insulin, to a target |
| 09/02/2008 | US7420050 TGF-β-specific covalently closed antisense molecule |
| 09/02/2008 | US7420045 IAPs associated cell cycle proteins, compositions and methods of use |
| 09/02/2008 | US7420042 Soluble neuropilin/growth factor receptor fusion proteins |
| 09/02/2008 | US7420037 Heat shock protein-based vaccines and immunotherapies |
| 09/02/2008 | US7420036 Angiogenesis factor diseases; antiproliferative agents |
| 09/02/2008 | US7420034 Of given sequence; human leukocyte antigen; induce cytotoxic T cells; use in vaccines |
| 09/02/2008 | US7420033 Composition of lactoferrin related peptides and uses thereof |
| 09/02/2008 | US7420032 Polypeptide of given sequence; detecting presence of antibody against tumor associated antigen of cancer in sample; kits |
| 09/02/2008 | US7420031 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells |
| 09/02/2008 | US7420030 Mimetic amino acid sequences for use in prevention and treatment of cell proliferative disorders |
| 09/02/2008 | US7420029 A tissue-specific transporter function inhibitor has both a ligand structure recognized by a tissue-specific transporter and a polymeric molecular structure incapable of passing through a membrane tissue |
| 09/02/2008 | US7420028 Replikins and methods of identifying replikin-containing sequences |
| 09/02/2008 | US7420002 Amino acid conjugates providing for sustained systemic concentrations of GABA analogues |
| 09/02/2008 | US7419970 Cosmetic compositions comprising N-acylamino amides |
| 09/02/2008 | US7419966 Viricides; human t-cell leukemia, lymphoma virus |
| 09/02/2008 | US7419957 Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods |
| 09/02/2008 | US7419956 Isolated physiologically active peptide and use thereof |
| 09/02/2008 | US7419955 Especially from intimal thickening, by administering a C-terminal globular domain of adiponectin to down-regulate expression of scavenger receptor A |
| 09/02/2008 | US7419954 Treating a Staphylococcus aureus infection by administering an antibiotic and a cyclic peptide containing a unit from a synthetic or a biosynthetic amino acid which, after cyclization, contains a lactone, thiolactone, lactam or carbonyl-containing ring |
| 09/02/2008 | US7419953 Selective R-cadherin antagonist and methods |
| 09/02/2008 | US7419952 Use of exendins and agonists thereof to treat diabetes |
| 09/02/2008 | US7419951 Administering a peptide |
| 09/02/2008 | US7419950 Methods of inhibiting ectopic calcification |
| 09/02/2008 | US7419949 Coagulation; prevent bleeding |
| 09/02/2008 | US7419948 Recombinant human Factor IX produced by a transgenic pig having an exogenous DNA stably integrated into its genome that secretes the biologically active Factor into its milk; the factor may be gamma -carboxylated |
| 09/02/2008 | US7419824 BASB006 polypeptides from Neisseria meningitidis and immunogenic compositions thereof |
| 09/02/2008 | US7419814 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 09/02/2008 | US7419807 High molecular weight; isolated nucleic acid; use in detecting antibodies in test sample; diagnostic kit |
| 09/02/2008 | US7419805 A polynucleotide encoding a carboxy-truncated interferon gamma (IFNG) polypeptide mutant exhibiting IFNG receptor binding activity having the amino acid sequence, SEQ ID NO:12, or 1-10 residue modifications; antitumor, -carcinogenic agent; viricides; interstitial lung diseases; autoimmune diseases |
| 09/02/2008 | US7419804 CASH (Caspase Homologue) with death effector domain, modulators of the function of FAS |
| 09/02/2008 | US7419803 Nucleic acids encoding human coagulation Factor VII polypeptides |
| 09/02/2008 | US7419799 Medical diagnosis; gene expression; genetic engineering; cell proliferation |
| 09/02/2008 | US7419794 Antibodies specific for CYP1B1 |
| 09/02/2008 | US7419790 Sodium-independent transporter carrying acidic amino acid and its gene |
| 09/02/2008 | US7419789 Method of inhibiting binding of Dengue virus to a human cell with DC-SIGN blockers |
| 09/02/2008 | US7419781 Of given sequence, with post-translational modifications; use in drugs for treating bacterial infections |
| 09/02/2008 | US7419776 Method of reducing pathogen load |
| 09/02/2008 | US7419690 Method for enhancing proliferation of bone marrow cells or spleen cells with an ethanol-insoluble extract of dioscorea |
| 09/02/2008 | US7419683 Method of inhibiting side effects of pharmaceutical compositions containing amphiphilic vehicles or drug carrier molecules |
| 09/02/2008 | US7419676 Activatable recombinant neurotoxins |
| 09/02/2008 | US7419675 Method for treating peritoneal adhesions |
| 09/02/2008 | US7419670 Method of treating arthritis with SERP-1 and an immunosuppressant |
| 09/02/2008 | US7419667 Drug for cancer therapy |
| 09/02/2008 | US7419664 Expression or activity of soluble CLCA1(chloride channel A1) is up-regulated, by administering inhibitors of soluble CLCA1 |
| 09/02/2008 | US7419658 Isolated ligand of ChemerinR |
| 09/02/2008 | US7419600 purifying polymer by ion exchange chromatography to obtain a purified polymer |
| 09/02/2008 | CA2623733A1 Supplements for pain management |
| 09/02/2008 | CA2397773C Universal procedure for refolding recombinant proteins |
| 09/02/2008 | CA2389333C Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 09/02/2008 | CA2372053C Compositions and methods for cancer treatment by selectively inhibiting vegf |
| 09/02/2008 | CA2351665C Antagonistic analogs of gh-rh inhibiting igf-i and -ii |
| 09/02/2008 | CA2316052C Sustained release formulations of water soluble peptides |
| 09/02/2008 | CA2306350C Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics |
| 09/02/2008 | CA2246430C Protein tyrosine phosphatases of hematopoietic cells |
| 09/02/2008 | CA2232527C Anti-inflammatory agent |